best liver cancer treatment in india Archives - Cancer Rounds

Install App For Better User Experience

Myths And Facts About Breast Lumps And Cancer

Self Examination Is The Key To Insight, A Key To Wisdom”

Breast cancer is one of the most common cancers among Indian women, with a rate of 25.8 per 100,000 women and a mortality rate of 12.7 per 100,000 women. Not only the numbers are increasing each day but also the myths and doubts about breast cancer. It is recommended to do breast self-examination monthly in about 3 to 5 days after the period starts. When you feel a lump in your breast or you experience any breast cancer symptoms, it’s understandable to be concerned. But don’t panic and jump to conclusions. Instead, act wisely and call your doctor to discuss.

Also, make sure you are away from these popular 7 myths of cancer and know the facts.

Myth No. 1: A Breast Lump Is Certainly Cancer

Eight out of ten breast lumps felt by women aren’t cancer. A cyst (a sac) or a fibroadenoma (an abnormal growth that isn’t cancer) are the most common types. During a woman’s menstrual cycle, some lumps appear and disappear.

It’s impossible to tell what it is based on how it feels. You should consult a doctor to know in detail about the lump.

 

Myth No. 2: Don’t come to a conclusion if you have a lump and your mammogram is normal.

More tests, such as an MRI, ultrasound, or a follow-up mammogram, may be required to examine the lump again.

A biopsy, in which a doctor takes a small sample of the lump to test it, may also be required. Regular examination is the ultimate key to detecting/preventing breast cancer.

 

Myth No. 3: Breast cancer lumps are always painless.

Certainly not. Breast cancer isn’t always painful, and having breast pain doesn’t rule out the possibility of cancer.

When there is a lump, inflammatory breast cancer symptoms such as redness, swelling, tenderness, and warmth in the breast, can be painful.

 

Myth No. 4: You Can’t Have Cancer If You Find a Lump While Breastfeeding

Breastfeeding reduces your chances of getting breast cancer, but it can still happen. Don’t ignore a lump if you notice it while breastfeeding. Always discuss with your doctor and go for a suggestive diagnostic test.

 

Myth No. 5: A Breast Lump Can’t Be Cancer If You’re Young

That is not the case. Breast lumps should be self-examined every month as mentioned earlier about 3-5 days after the period starts at any age.

Even though the majority of women diagnosed with breast cancer are past menopause or over the age of 50 years, stats are rapidly changing and a lump in the breast can be cancerous in a younger woman too.

 

Myth No. 6:  A smaller size of lump is less likely to be cancerous than a larger size lump. 

This is certainly not true. Breast lumps irrespective of the sizes, should be discussed with the oncologist or the gynecologist and should be considered for suggestive diagnostic tests. At times, small lumps may progress to aggressive cancers and shouldn’t be ignored.

 

Myth No, 7: If you don’t have a family history of breast cancer, a lump is probably harmless.

If no one in their family has had breast cancer, many women believe they aren’t at risk. That is not the case. According to the American Cancer Society, only about 15% of women with breast cancer have a relative who has had the disease. Whether or not breast cancer runs in your family, have all lumps examined by a doctor.

For more informative content on various types of cancer, its diagnosis, queries and the breast cancer treatment in India, visit our website www.cancerrounds.com.

Posted by, magneto
February 9, 2022

Options to Preserve Fertility In Female Cancer Survivors

For cancer survivors to preserve fertility is the first physiological need these days. And fertility preservation thus is becoming increasingly significant to improve the quality of life in cancer survivors. The ability to have children is called fertility. Best hematologist in India and oncology team of the best cancer hospital in Gurgaon collectively advocate the recommended guidelines suggesting that discussion of fertility preservation should be done prior to starting cancer therapies. 

Globally there is a lack of implementation in this area but India is leading with the solution as the oncologist team has session of counselling for patient in lieu of cryopreservation and fertility preservation. 

To briefly introduce, with the research and innovations in the are there are number of techniques available for fertility preservation, and they can be used individually or together in the same patient to maximize efficiency.  

Adding to this, Oocyte and embryo cryopreservation are now established techniques. The cryopreservations have their limitations but every lock has key. Ovarian tissue cryopreservation is a wider clinical application with the advantage of keeping the fertility window open for a longer time. Both the conventional arms of treatment, chemotherapy and radiotherapy have a major impact on reproductive potential. This is indicative of fertility preservation procedures – that should be carried out prior to these treatments.  

Cancer in females of reproductive age accounts for nearly 10% of new cancer diagnoses. Most common cancers presenting in this group of youth affecting female include breast, thyroid, cervical, uterine, melanoma, lymphoma, and colon cancer. Over the past four decades, advances in surgery and adjuvant therapy have led to improved 5-year survival rates for breast (85.5%), endometrial (91%), cervical (83.2%), and ovarian cancers (79.5%). These improved outcomes have resulted in an increased number of cancer survivors but many therapies are harmful to the ovaries and put women at risk of premature ovarian failure and infertility. This is significant as nearly 25% of today’s cancer survivors are reproductive-aged woman who may wish to have children. Embryo cryopreservation is a widely established method for preserving reproductive capacity and due to its high pregnancy rates, it is considered the “gold standard” fertility preservation option. This procedure is offering the best chances of a live birth in the future as well. This solution also works in cases of male, that means the male cancer patient may store his sperm before treatment. Doing this is a way of preserving fertility. 

But, in case you have undergone chemotherapy treatment then still no need to worry. After cancer treatment also, the ovarian tissue can be thawed and placed in the pelvis (transplanted). Once the transplanted tissue starts to function again, the eggs can be collected and attempts to fertilize them can be done in the lab. A man may have no sperm in his semen after cancer treatment. But he may still have healthy sperm in his testicles. During a testicular sperm extraction, the doctor removes small pieces of testicular tissue. Any healthy sperm cells found in this tissue can be used to make a baby. 

The need for fertility preservation has not yet weighed against morbidity and mortality associated with cancer. Thus, a multidisciplinary collaboration between oncologists and reproductive specialists to improve awareness and availability is a necessity. 

Posted by, magneto
February 2, 2022

The Fourth Stanchion in The Treatment World of Cancer is Interventional Oncology- As Multidisciplinary Arm of Treatment

One of the recent evolving branches of interventional radiology, which relies on highly sophisticated treatment tools accompanied by precise imaging guidance to target and destroy malignant tumors are referred to as Interventional Oncology.

The field of Interventional Oncology is an important pavement to potential benefits for both patients and the healthcare system.

Being a new discipline multidisciplinary treatment arm, interventional oncology is considered by the best hematologist in India as the wider field of oncology. In the cancer hospital Gurgaon, all oncologists, and experts prefer, its application in regard to a cornerstone of modern cancer care.

Yes, interventional oncology offers strong collaboration between radiation oncology and interventional oncology, aiming at treatment or cure means treatment with remission or palliative cure.

A robust quality-assurance framework to support the integration of interventional oncology into multidisciplinary care provides benefits to health care practitioners, cancer patients, and to the wider field of oncology research as well. A recent offshoot of interventional radiology is interventional oncology has evolved as an independent stanchion within multidisciplinary oncologic care.

Intervention oncology is one of the minimally-invasive image-guided tumor therapy defined as comprehensive unlimited technological innovation. Best hematologist in India and best oncologist in Mumbai refer patients for Interventional oncology with the expectation that minimally-invasive therapies incorporated in oncologic care plans with sister disciplines will gratify a new level of clinical collaboration. This is predicted to research results of many years and is more based on prospectively collected clinical evidence. An Interventional Oncology -IO practice is preferred in treatment regimen by a young generation that includes procedures like minimally-invasive, image-guided tumor therapies.

Workbench for an interventional oncologist incorporates less un-common services for cancer patients including venous/enteral access, biopsies, and palliative procedures. Mentioned cancer care tool kit is representing the initial point of contact. Followed by therapeutic concepts and rapid solutions for increasingly complex Carcinogenesis with symptom relief as a common result. The satisfaction rate in terms of patient analysis and quality care index pick a spike with an excellent impression of referring physicians and treating oncologists.

Cancer is now the leading cause of death worldwide and at the same time, medicine as a whole is undergoing a phase of transformation in the light turning to the dark of declining reimbursements. Recent advances have provided interventional oncology as a different treatment and the unique position of the treatment world of oncology. Being a technology-driven specialty, it is able to fulfil the professional requirements for highly specialized experts who have the skill and the will to grow a practice.

Maintaining and expanding the fourth stanchion of clinical oncology requires steps above the technical skills learned in a fellowship. For these interventional oncologists are ready to speak the language of oncology, which ensures broadening knowledge of the science and practice of interventional oncology.

Interventional oncology as a separate branch to communicate in oncology streams as a multidisciplinary arm focuses on the fundamentals of the other oncologic disciplines to be widely accepted treatment in guidelines for various cancers as well.

Our obligation of clinical research and development by Interventional Oncology upholds the rigid standards of evidence-based medicine and is surely an evolving oncological solution. Tremendous progress has been made over the last decade, to which an example is a trial involving the ability to influence clinical guidelines in lieu of hepatocellular carcinoma. In these two therapies performed by interventional oncologists, ablation and chemoembolization, are incorporated into official treatment guidelines globally. And new norm for answering clinical questions based on prospective multicentre phase II or III studies, either single-arm or randomized is on rapid research events.

To conclude Interventional Oncology is an exciting area which is exploiting vascular and non vascular procedures similar to or identical to other procedures performed by Interventional Radiologists. This allows oncologists in making practice development feasible to use physician extenders to maximize efficiency in practice.

Posted by, Medical Team, Cancer Rounds
January 18, 2022

Contact Us

    User
    Mobile Number
    Message
    whatsapp